[The use of radiopharmaceuticals for myocardial perfusion in oncological diagnosis].

Recently, radiopharmaceutics for myocardial perfusion are widely used in oncological diagnosis, not merely supplementing the other methods of examination, but having also an independent role both in terms of making exact diagnosis, and in evaluating the diffusion of malignant tumors, as well as in estimating the results of the therapy undertaken. Their widespread implementation in practice is still not well enough studied, and awaits further clarification.